Alcobra Ltd.
(NASDAQ : ADHD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ADHD News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-2.41%16.1810.2%$210.07m
SHPGShire PLC Sponsored ADR
-2.24%181.290.3%$191.23m
PRGOPerrigo Co. Plc
0.40%84.414.3%$132.58m
MNKMallinckrodt Plc
-2.00%53.3811.1%$108.85m
MDCOMedicines Company
0.42%52.0619.0%$105.28m
ENDPEndo International Plc
-1.79%13.159.0%$90.85m
PRXLPAREXEL International Corporation
0.09%65.947.5%$85.48m
UTHRUnited Therapeutics Corporation
-0.50%146.7112.7%$84.75m
ICPTIntercept Pharmaceuticals, Inc.
2.81%119.1921.9%$71.58m
JAZZJazz Pharmaceuticals Plc
0.52%136.112.3%$64.77m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.45%123.7410.9%$47.54m
SAGESAGE Therapeutics, Inc.
-0.05%62.3012.1%$46.23m
PTLAPortola Pharmaceuticals, Inc.
4.17%33.508.8%$43.98m
HZNPHorizon Pharma plc
1.75%17.4511.1%$41.47m
SGYPSynergy Pharmaceuticals, Inc.
0.18%5.4916.1%$39.93m

Company Profile

Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.